6 Comments
User's avatar
Alison Conley's avatar

Thanks for the link to the presentation from FDAs Kathleen Culver. I’m under the impression from reading your substack, pharmas decision to outsource cGMP will never work. 1. Pharma can’t bring new products to market safely and 2. Their existing supply chains are vulnerable to contamination and adulteration. It sounds like they urgently need to bring everything back in house. I imagine this will be a significant undertaking. Now that I’ve been following you for several months I’m not sure if I like the idea of taking an aspirin. If pharma is having trouble manufacturing heparin, a drug that’s been in the market for years, how could they possibly manufacture the SARSCoV2 injections safely in 9 months!

Expand full comment
Paul  Barbara's avatar

'...WHAT DOES THIS MEAN FOR SARS-COV-2 INJECTIONS?...'

Well, I should think any adulteration would be an improvement on the DoD/Big Pharma Bioweapons!

Expand full comment
JAS's avatar

You nailed it!

Expand full comment
Hedley Rees's avatar

Thanks Jas!

Expand full comment
Sunface Jack's avatar

The adulterated product was found to have caused nine patient deaths and 574 serious adverse events (SAEs).

Was anyone charged for the murders?

Expand full comment
Crixcyon's avatar

There are a million other things out there trying to take you out. Why speed up the process by using vaccines, mRNA poisons and drugs? They screw up some drug and even if a few thousand are murdered, they go right on making drugs. The dead never come back but the drug makers always do. Usually with a vengeance.

Expand full comment